Related Experiment Video
Updated: Jun 1, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Hepatitis C virus infection in children]
Miriam Cuarterolo1, Susana López, Mirta Ciocca
1Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan. mcuarterolo@intramed.net
Archivos Argentinos De Pediatria
|June 11, 2011
Summary
Hepatitis C virus (HCV) spreads mainly from mother to child. While often asymptomatic in children, liver disease can progress, necessitating HCV-RNA testing and effective treatments like peginterferon and ribavirin.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Context:
- Hepatitis C virus (HCV) affects 3% of the global population.
- Vertical transmission (mother-to-child) is the predominant route of HCV spread.
- HCV infection poses a significant public health challenge worldwide.
Purpose:
- To summarize the transmission, diagnosis, and treatment of hepatitis C virus infection, with a focus on vertical transmission.
- To highlight the limitations of antibody testing and the importance of HCV-RNA determination.
- To outline current therapeutic strategies and future research directions for HCV.
Summary:
- Hepatitis C virus (HCV) is transmitted parenterally, sexually, and vertically; vertical transmission is currently the primary mode of spread.
- Most infected children are asymptomatic, but liver disease progression can occur.
- HCV-RNA testing is crucial as antibody positivity does not distinguish active from resolved infections.
- Peginterferon combined with ribavirin is the most effective current treatment.
Impact:
- Understanding HCV transmission dynamics is vital for implementing effective prevention strategies.
- Accurate diagnostic methods, such as HCV-RNA testing, are essential for managing infected individuals.
- Current treatments offer a viable option, but ongoing research into new drugs and vaccines is critical for long-term disease eradication.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...